BIOLIFE SOLUTIONS INC·4

Aug 21, 9:10 PM ET

Casdin Capital, LLC 4

4 · BIOLIFE SOLUTIONS INC · Filed Aug 21, 2025

Insider Transaction Report

Form 4
Period: 2025-08-15
Transactions
  • Sale

    Common Stock, par value $0.001 per share

    2025-08-15$24.40/sh500,000$12,200,0006,707,165 total(indirect: See footnote.)
Footnotes (1)
  • [F1]The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC ("Casdin Capital"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.

Documents

1 file
  • 4
    ownership.xmlPrimary